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Abstract
Objective—To find, review, and critically evaluate evidence pertaining to the phenomenology of
pediatric bipolar disorder and its validity as a diagnosis.
Methods—The present qualitative review summarizes and synthesizes available evidence about
the phenomenology of bipolar disorder (BD) in youths, including description of the diagnostic
sensitivity and specificity of symptoms, clarification about rates of cycling and mixed states, and
discussion about chronic versus episodic presentations of mood dysregulation. The validity of the
diagnosis of BD in youths is also evaluated based on traditional criteria including associated
demographic characteristics, family environmental features, genetic bases, longitudinal studies of
youths at risk of developing BD as well as youths already manifesting symptoms on the bipolar
spectrum, treatment studies and pharmacologic dissection, neurobiological findings (including
morphological and functional data), and other related laboratory findings. Additional sections
review impairment and quality of life, personality and temperamental correlates, the clinical utility
of a bipolar diagnosis in youths, and the dimensional versus categorical distinction as it applies to
mood disorder in youths.
Results—A schema for diagnosis of BD in youths is developed, including a review of different
operational definitions of `bipolar not otherwise specified.' Principal areas of disagreement appear
to include the relative role of elated versus irritable mood in assessment, and also the limits of the
extent of the bipolar spectrum – when do definitions become so broad that they are no longer
describing `bipolar' cases?
Conclusions—In spite of these areas of disagreement, considerable evidence has amassed
supporting the validity of the bipolar diagnosis in children and adolescents.
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Bipolar disorder (BD) in children and adolescents has been a controversial topic that has
received a great deal of recent scholarly and popular interest. There has been a tremendous
increase in the number of trade books, articles in the popular media, and even television
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shows on the topic of BD (1), and there has been a similar rise in the rate at which it is being
diagnosed and treated in youths. Although it was once considered primarily an adult-onset
disorder, more than 100,000 children were being medicated for BD in 2001 (2), with the
percentage of children being clinically diagnosed more than doubling in the last 10 years (3,
4). Fortunately, the amount of research on the topic has also surged over the same time
period, and there are significant areas of consensus in the findings (5–8).
The purpose of this paper was to review the available evidence about classic diagnostic
validators as they apply to the diagnosis of BD in children and adolescents (9, 10). These
include (i) phenomenology, (ii) demographic characteristics, (iii) family environmental
characteristics, (iv) genetics, (v) longitudinal course, and (vi) neurobiology. This paper is
not intended to be a comprehensive review of assessment or treatment strategies, but instead
touches on these topics as they pertain to the validity of the bipolar diagnosis in youths.
There have been fairly recent reviews on both assessment (11) and treatment guidelines (12,
13) that expand on clinical issues. It is worth noting that treatment response is considered
one of the facets of validating a diagnostic entity (9), and so treatment reviews can be read
with this in mind. After presenting the validity findings, the paper discusses what is known
about sex and cultural differences, the implications of categorical versus dimensional
approaches to diagnosis, what is known about temperament and personality correlates, and
the burden associated with bipolar illness. In addition, working with youths typically
requires involvement of parents, teachers, or other parties that raise issues of cross-
informant agreement, impairment in single versus multiple settings, and boundary issues in
terms of separating normative and pathologic behavior. The paper concludes with
recommendations for refining diagnosis in youths, as well as identifying principal areas for
future study.
Classical diagnostic validators of the construct of pediatric bipolar
disorder
Phenomenology
Several different research groups have investigated the phenomenology of pediatric BD,
using different approaches in terms of subject ascertainment, clinical interviewing (e.g.,
choice of diagnostic interview, level of training of the interviewer), choice of informant
(e.g., parent only, parent and child, and adolescent only), method of reconciling discrepant
information from multiple informants (e.g., algorithms such as consistently taking the higher
score as the summary, versus using clinical judgment or joint interviews to reconcile
differences), and different age groups. A recent meta-analysis synthesized seven published
studies, and statistically tested whether there were differences in findings that were too large
to attribute to random effects differing across studies (6). Meta-analytic methods indicate
that there is considerable consistency in findings about the symptom presentation and
diagnostic comorbidity associated with pediatric BD, especially after considering
differences in methodology. In particular, there appears to be consensus that periods of
increased energy will be evident in nearly 90% of cases with pediatric BD, and grandiosity
will be clinically noteworthy in nearly four of five cases with pediatric BD (6). There was
also general consensus that most other conventional symptoms of mania will manifest in 70–
85% of cases with pediatric BD, with the exceptions of `flight of ideas' (occurring in 56% of
pediatric BD cases on average) and hypersexuality (occurring in a mean of 38% of pediatric
BD cases). These patterns of symptom presentation also appear to be consistent with a
recent analyses of a large group of children and adolescents with bipolar spectrum disorders
(14) and what is being described as the phenomenology of cases with early onset BD in
Europe (15) and America (14). Table 1 lists the symptoms of mania, along with associated
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features, and reviews presentations that would be more specific to mania as opposed to other
diagnoses.
Elated mood—The two symptoms showing the most highly discrepant rates across studies
are elated/euphoric mood and irritability. Some treat elated mood as a `cardinal' symptom of
mania, arguing that people not displaying periods of abnormally elevated mood (or perhaps
grandiosity) should not be classified as having mania or a bipolar diagnosis (5). Other
groups see high rates of irritable mood, including irritability in cases where pathologic
elevations of mood do not appear evident (16, 17). Data across research groups indicate that
elated mood is highly specific to BD. Episodes of elated mood that are developmentally
abnormal in terms of context, frequency, intensity, or duration appear to rarely occur outside
of the context of a manic episode (6–8, 14, 18). As a result, the presence of elated mood
helps rule in the diagnosis of a bipolar illness (19). However, requiring the occurrence of
elated mood could lead to the underdiagnosis of bipolar illness, as the sensitivity of the
symptom is imperfect. Also, elated mood is not as impairing as other symptoms, and
families will often describe episodes of frank exalted mood, and then say, `I was not worried
about it at the time, because at least he/she seemed happy, instead of violent.' Further, elated
mood by itself is also not sufficient to warrant a diagnosis of mania or hypomania, but
instead needs to co-occur with other manic symptoms. Finally, there also appear to be cases
for whom the predominant mood during mania or mixed episodes may be irritability.
Irritability—From a diagnostic point of view, irritability appears to be the complement of
elated mood. The vast majority (80%+) of bipolar cases demonstrate periods of clinically
marked irritability (i.e., high sensitivity) (6, 8, 14). However, irritable mood is not specific to
BD. Instead, it appears analogous to `fever' or `pain' – it is a clear indication that something
is wrong, but by itself it cannot provide clear guidance about exactly what the problem
might be (20). Questions probing irritable mood occur in at least seven different modules in
the semi-structured diagnostic interviews that are considered the research standard for
assessment of pediatric BD (21): depression, mania, generalized anxiety disorder, post-
traumatic stress disorder, oppositional defiant disorder, conduct disorder, and obsessive/
compulsive disorder (22, 23). Irritable mood and aggressive behavior are also often
associated with other disorders such as autism and Aspergers, attention-deficit hyperactivity
disorder (ADHD), mental retardation, and adjustment disorders (20). Some argue that the
severity of the aggressive behavior might distinguish BD from other conditions (24–26).
Severity, however, is likely to be misleading in settings where the behavior of most patients
is extremely impaired (such as inpatient units) or where aggression is likely to be common
for other reasons besides mood disorder (such as forensic settings). On the other hand,
aggression is one of the most distressing and impairing symptoms associated with pediatric
BD as well as other conditions (27). Thus, aggression is likely to be a main `presenting
problem,' and treatments will need to reduce aggression to be seen as effective. Also,
because irritable mood is so sensitive to pediatric BD, the absence of any episodes of
irritability and aggressive behavior effectively `rules out' a diagnosis of pediatric BD unless
numerous other risk factors, or symptoms such as euphoria, are present; or unless BD is
unusually common in a particular clinical setting (19). Aggression that is markedly episodic,
and that co-occurs with other symptoms of mania, should definitely trigger careful
assessment of mood pathology and family history of mood disorder.
Grandiosity—Some have suggested that grandiosity could also be considered a `cardinal'
symptom of pediatric BD (5). However, a fairly large percentage of youths with pediatric
BD fail to show this symptom (6). At the same time, a large group of youths without
pediatric BD will show inflated self-esteem and arrogance. These traits are a core feature of
antisocial behavior and contribute to several of the 20 items comprising the Psychopathy
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Checklist-Revised (28) and its adapted versions for youths (29). Early reports of the
phenomenology of pediatric BD may have overestimated the specificity of this symptom to
pediatric BD, because youths with diagnoses besides ADHD or pediatric BD were excluded
from the sample (30) – thus eliminating youths with conduct disorder and other precursors
to antisocial personality disorder. Moreover, there appear to be potential differences in
cultural and research operational definitions of what constitutes pathologic grandiosity (31,
32). Adding to the complexity, clinical grandiosity can be a challenge to recognize in
younger children, because they may fantasize that they are the `best' dancer, football player,
and so forth – all as part of developmentally appropriate imagination. Adolescents,
particularly those with narcissistic personality traits, can also be quite grandiose, without a
mood disorder necessarily being involved. Substance use can also trigger experiences of
grandiosity. Fluctuations in self-esteem and grandiosity are theoretically more promising as
a construct that would differentiate pediatric BD from other conditions such as conduct
disorder, where inflated self-esteem would be more trait-like (33, 34).
Two other symptoms that appear to be fairly specific to BD are hypersexuality and
decreased need for sleep. Hypersexuality in the absence of sexual abuse and exposure to sex
(movies, or witnessing others having sex) appears to occur in less than half of cases with
pediatric BD (6), but it is very rare to encounter in children outside of the context of abuse
or mania. Similarly, decreased need for sleep is not evident in all cases of pediatric BD, but
when a child or adolescent only sleeps 2 or 3 hours at night and the next day is not tired,
then the behavior indicates need for careful evaluation of potential BD.
Finally, psychosis also appears to be associated with pediatric BD. Most research groups
have found that approximately one-fifth of youths meeting diagnostic criteria for bipolar I
will also have hallucinations or delusions during the course of a mood episode (6). When
groups have identified substantially higher rates of psychosis, the discrepancy appears
attributable to differences in the operational definitions of `psychosis' (31, 32). The presence
of hallucinations or delusions in a youth should trigger careful evaluation for mood disorder,
for even though pediatric BD is uncommon, it appears much less rare than early-onset
schizophrenia or other potential causes of psychotic features in children.
Symptoms that appear unhelpful in the assessment of pediatric BD: Data are
consistently emerging to indicate that some symptoms are less helpful in the assessment of
pediatric BD. Many of these are behaviors that, although strongly associated with pediatric
BD, are not specific to the disorder, and thus often occur in the context of other conditions.
Difficulty concentrating, high motor activity, and aggression are examples of symptoms that
do not appear diagnostically specific (6). Although these symptoms may not be helpful in
differential diagnosis, they can play a central role in treatment planning and outcome
evaluation. When these symptoms are present, evaluators should be careful to gather
information about whether the symptoms appear to ebb and flow with other mood symptoms
and changes in energy, versus having a more chronic presentation suggestive of other
disorders. Diagnostic assessment should also consider the possibility that the symptoms
might be accounted for by substance abuse, medication interactions or side effects, or (more
rarely) some other general medical condition (35).
There are other symptoms that appear less useful both diagnostically and in terms of
evaluating treatment. These include `lack of insight' and `bizarre appearance', 2 of the 11
symptoms assessed on the industry-standard measure of severity of manic symptoms, the
Young Mania Rating Scale (YMRS) (36). These two symptoms are compromised by
developmental changes in the degree of insight that might be expected, as well as by cultural
differences in appearance that might constitute `adolescent experimentation.' Objectively,
these two items do not load significantly on a general factor of manic behavior (37, 38), and
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they actually lower the reliability of the YMRS total score when included (37, 39). For all of
these reasons, youths would be better served by de-emphasizing or eliminating these
symptoms from evaluations of pediatric BD.
Ultradian cycling versus mixed states: One of the main points of seeming departure
between descriptions of pediatric BD versus adult bipolar phenomenology pertains to rates
of cycling. The `rapid cycling' variant of BD in adults requires that a patient have four
distinct mood episodes over the course of a year, regardless of polarity. The presence of four
or more annual episodes is a clinically significant feature, auguring an earlier age of onset, a
more chronic course, less response to lithium, and greater comorbid substance use (40, 41).
Descriptions of pediatric BD have involved careful characterization of mood
phenomenology, including the rate of mood switches or cycles between polarity (5, 8).
Detailed counts of the shifts in mood have led to estimates that some youths with pediatric
BD experience thousands or tens of thousands of mood swings over the course of a year (5).
These figures have been met with skepticism in some quarters, given that four episodes per
year would portend bad outcomes in adult psychiatry. Apparent differences are probably due
to discrepant operational definitions, and it is most likely that the clinical presentations are
more similar than quantitative estimates might suggest. One recently clarified issue is the
distinction between a `cycle' (a pronounced shift in mood and energy from one extreme to
another) versus an `episode,' technically denoting an extended period of mood dysregulation
often encompassing multiple cycles in polarity (42, 43). The pediatric BD data have often
been reporting high rates of cycling, whereas the number of distinct episodes appears to be
small, with long duration, some recovery or remission, but also a high risk of relapse (8, 43,
44).
The second, more subtle phenomenological issue involves different clinical presentations
that could legitimately fit into the `mixed' category. Broadly speaking, two major categories
might be referred to as the `chocolate milk' and `fudge ripple' versions of mixed states. The
`chocolate milk' version takes symptoms of depression and symptoms of mania, and
dissolves them together into a new, homogeneous state that is qualitatively different from
either component, and it is not possible to isolate a sample from the new state that is a pure
example of either depression or mania (45, 46).
However, it is also possible to satisfy DSM criteria for a mixed state by showing a `fudge
ripple' presentation, where there are `chunks' of manic and `chunks' of depressive symptoms
manifest for much of each day, most days of the week (45). A week's worth of such
presentation might show clear ripples of both mania and depression every day of the week,
yet a more fine-grained analysis could distinguish distinct periods within each day that were
associated with different mood polarities (47). This sort of volatile, shifting mood
presentation appears to be a common expression of mixed states in BD in adults, and
progressively more common in younger age groups (48). The similarity in clinical
presentation has probably been obscured by confusion about the distinction between
episodes versus cycles, and also by differences in the conceptualization of mixed states
versus `ultradian' cycling, which are likely to be labels for the same underlying clinical
phenomenon.
Chronicity versus periodic episodes: are distinct episodes necessary for bipolar
disorder?: A point of contention has been whether youths with chronic mood dysregulation
should be considered as being on the bipolar spectrum. Some groups argue that mood is
often pervasively irritable, that the onset of a mood illness can be insidious versus involving
an acute change in functioning, and that the mood remains irritable for spans of months or
years at a time (17). Others argue that there should be clear fluctuations in mood and energy
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if the behaviors are due to a mood disorder (5), even if there is irritable mood both in the
context of depression and mania (7).
Episodic presentation of mood disturbance is associated with differences in the course (49,
50) and treatment response of BD (51). For youths at familial risk of developing BD,
subsyndromal episodic mood disturbance appears to be a precursor to full-blown mood
episodes (52, 53). One speculative possibility is that mood disturbance falls along a
continuum of episodicity, with longer and more discrete episodes characterizing 'classic'
bipolar I, and briefer and more frequent mood episodes characterizing rapid cycling variants,
which in turn might shade into the chronic mood dysregulation labeled as `borderline
personality disorder' in adults (54). An alternate possibility is that there are at least two
gross, overarching subtypes of BD: an episodic version that may be more responsive to
lithium and shows other characteristics of `Cade's Disease' (55) and a more chronic version
with poorer lithium response and higher rates of comorbidity (56).
Bipolar not otherwise specified or subsyndromal bipolar disorder
There have been a variety of different operational definitions used for BD `not otherwise
specified (NOS).' Table 2 presents recognized clinical definitions of bipolar spectrum
disorders, as well as more provisional research definitions. These include having mood
disturbance but an inadequate number of `B Criteria' symptoms (8, 57, 58), versus having
enough symptoms but inadequate duration of the index mood states (8, 59), as well as
possibly requiring periods of elevated mood or grandiosity as a way of `narrowing' the
phenotype, versus more chronic severe mood dysregulation (60). There is some evidence
that bipolar NOS is on a spectrum with bipolar I, showing levels of mood disturbance and
family history of mood disorder that on average fall in between the rates in bipolar I versus
other mood disorders (14). Roughly 20% of youths initially meeting criteria for bipolar NOS
progress to meet full criteria for bipolar I or bipolar II within <2 years (8). Although
research groups have been using somewhat different definitions, a consistent picture is
emerging that bipolar NOS is a highly impairing condition in youths, deserving of clinical
attention.
Comorbidity
Robins and Guze discussed clinical comorbidity as an example of clinically `associated
features' that might help validate a diagnostic construct if a consistent pattern emerged
across investigations (9). Studies of pediatric BD have repeatedly found high rates of
comorbid ADHD (averaging 62%) (6), followed by elevated rates of oppositional/defiant
disorder or conduct disorder, substance abuse or dependence, and anxiety disorders (4, 5, 7,
14, 61). These patterns of comorbidity appear broadly consistent with the patterns of
comorbidity reported in adult bipolar samples (62, 63). ADHD and separation anxiety
appear as more common comorbidities with very early onset (prior to age 11) BD, whereas
substance use and eating disorder comorbidities appear more commonly observed in
adolescence. There is least clarity about the overlap with ADHD in adults. Until recently,
ADHD was presumed to be a pediatric condition that most would outgrow by adulthood.
More recent studies have found a substantial rate of ADHD to persist into adulthood (64),
and also elevated rates of ADHD in adult bipolar samples (65). Interestingly, even these
more recent studies have primarily relied on self-report in adult samples, which are prone to
underestimate the occurrence of ADHD (66), versus pediatric samples using parents and
teachers, who are more sensitive to ADHD. Thus, the pattern of comorbidity appears similar
between pediatric and adult BD, with ADHD deserving further inquiry using collateral
informants in adult samples.
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Extremely high rates of comorbidity raise concerns about whether ADHD and pediatric BD
are actually distinct disorders (67–70). Possibly, the inattention, motor activity, and anxiety
frequently seen in association with pediatric BD may actually be `core features' of the
condition and not indicators of psychiatry comorbidity involving multiple diagnoses (71).
However, a growing number of studies indicate that pediatric BD appears to be distinct from
ADHD in terms of familial aggregation patterns and clinical correlates (8, 59, 72, 73),
strongly indicating that cases with pediatric BD should not be conceptualized as simply
being an extreme variant of ADHD. When ADHD is superimposed on pediatric BD, this
may reflect a distinct subtype of illness (73, 74).
Demographics
Non-clinical epidemiologic data do not yet afford investigation into potential demographic
differences in the incidence of pediatric BD. Clinical data appear to indicate that bipolar I
disorder shows no sex differences in incidence after adjusting for the fact that more young
males present to clinics for externalizing problems in general (4, 75, 76), nor are differences
in rates of cyclothymia or bipolar NOS evident. Some data show a possible higher rate of
bipolar II in female than male adolescents (8, 14, 76), consistent with adult data (77),
perhaps due to differences in referral pattern (with females being more willing to
acknowledge depressive symptoms or to seek treatment for them) versus being a true sex
difference in risk or incidence (78). However, females with BD often experience more
depressive episodes, whereas adult males exhibit more manic episodes (79), and adult
females may also show a higher rate of mixed states. Findings suggest that BD may occur at
equal rates in males and females in youth, but males may present with more mania and more
ADHD and females with more depression, consistent with adult findings (75, 76). Biological
sex also has not proven predictive of length of illness or time until relapse (14, 44).
Clinicians will need to be vigilant about the possibility of encountering BD in females
whose presentation is less likely to show pure mania or unmixed hypomania.
Minority youths with a mood disorder are more likely to be misdiagnosed with conduct
disorder or schizophrenia (80), and more likely to be treated with older and/or depot
antipsychotic medications (81, 82), similar to adult findings (83–85). Clinicians should be
careful to assess for mood disorder systematically with patients from ethnic minorities,
particularly when the presenting problem involves aggressive behavior or psychosis.
Clinicians should also be alert to the potential for racial bias in diagnosis when gathering
family history, making it prudent to gather symptom level information when possible to
ascertain familial risk.
Family environmental characteristics
Families with mood disorder show disrupted family functioning and greater conflict within
the family (86–88). This is partially because biological parents often have a mood disorder,
reflecting the heritable component of the illness. Families of youths with pediatric BD also
tend to show high levels of expressed (negative) emotion, which is linked with earlier age of
onset, more rapid relapse, and poorer response to treatment (44, 89, 90). At present, it is
unclear whether these associations represent a specific risk factor connected to pediatric BD,
versus being correlates of severe pathology in general (89, 91).
Genetics
At present there are no twin studies or adoption studies published that have specifically
focused on pediatric BD. It is well established that BD is (i) highly heritable (79, 92, 93), (ii)
not a single-gene disorder (94), (iii) a condition where partial genetic loading may actually
confer adaptive advantages (95, 96), and (iv) a condition where genetic variations may
moderate treatment response (51, 97). Greater familial loading for the condition may be
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associated with earlier ages of onset and more severe course (98–102). There is some
evidence suggesting progressively earlier ages of onset and more virulent course in recent
generations (64), potentially consistent with a `genetic anticipation' model (103, 104).
However, attempts to demonstrate the molecular genetic mechanism underlying anticipation,
such as expansion via trinucleotide repetition, have not yet been successful (92).
Investigations focusing on specific genes have so far failed to demonstrate statistically
significant associations with pediatric BD (105–107). This could be attributable to low
power for small but significant effects found in adult samples, or perhaps due to the genes
involved in pediatric onset being different from those in later onset (92), with the possible
exception of the neurotrophic factor Val66Met polymorphism (108). Several authorities
believe that pediatric-onset BD might actually represent one of the best choices of
phenotype for genetic investigations, because it is likely to have a more homogeneous and
penetrant genotype and greater familial loading (92, 109). There is also indication that there
may be susceptibility loci specifically influencing the age of onset of mania (110). Pilot
work is underway on multiple molecular genetic and familial aggregation and twin studies
that promise to greatly enrich our understanding of the genetic underpinnings of pediatric
BD.
Studies of youths at risk of developing BD
There have been multiple studies of offspring where at least one parent was affected by
mood disorder, often BD (111–114). Evidence strongly suggests that youths who have a
parent with BD have more than doubled risk of developing psychopathology in general, with
an even greater risk of developing a mood disorder, and the greatest risk differential for
developing a bipolar spectrum illness. The most recent meta-analysis found that 5% of the
youths at risk met criteria for a lifetime bipolar spectrum diagnosis at the time of
assessment, versus 0% of the youths in the comparison groups (114). Recent empirical
studies have found lifetime rates of BD as high as 10% when youths were followed to ages
16–26 (115).
There are several caveats relevant to the high-risk studies. The wide ranges in the rates of
bipolar illness found across studies cannot be attributed to sampling error, but instead are
partly due to differences in research instrumentation and in the definitions used for bipolar
symptoms and diagnoses. A second, related limitation is that most studies concentrated on
bipolar I, and to a lesser extent, bipolar II, presentations in the child, and did not gather
systematic data about cyclothymia and bipolar NOS. A third limitation is that these studies
typically did not follow the youths through the age of greatest risk for the development of
bipolar illness, thus underestimating the lifetime risk for these offspring. A fourth limitation
is that in most studies, raters were not blind to parent diagnoses, creating an opportunity for
bias in child diagnoses.
More recent studies address some of these limitations via longer follow-ups and reliance on
semi-structured interviews synthesizing information from both parent and child. These
studies are identifying precursors and potential prodromes of BD, such as early-onset
depression (115–117), or episodic problems with attention, anxiety, and aggression (52, 53,
115). These findings are also broadly consistent with follow-back studies investigating child
and adolescent symptomatology in adults with BD (65, 118–121).
Longitudinal course
Prospective studies provide important information about the phenomenology and diagnostic
evolution of pediatric BD, and they will be the most persuasive line of evidence about
continuity between the pediatric and adult definitions of BD (32). Longitudinal studies of a
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cohort initially ascertained before puberty have found that youths with pediatric BD tend to
show long episodes with frequent mixed states, and high rates of relapse following
remission or recovery (8, 44, 122). Substantial mood symptoms also appear to persist even
during periods between acute episodes, also consistent with recent findings in adults (123)
and especially those with younger ages of onset (41). Mixed states are the predominant
mood state for bipolar I and bipolar NOS, whereas depressed states are more common in
bipolar II (8). Overall, the rates of depression (including mixed states) appear to be higher
than sometimes described in initial assessments of young outpatient samples (7, 17) and
broadly consistent with what has been found in the adult literature (124).
Longitudinal work focusing on bipolar NOS is more scarce. Available findings indicate that
BD NOS may be associated with a more chronic course and continued impairment (8), even
though only roughly one-third have progressed into more classically defined and severe
mood disorder during follow-up periods ranging from 2 to 4 years (8; SY Kahana, EA
Youngstrom, JR Calabrese and RL Findling, unpublished data). In general, longitudinal
studies suggest that `fuzzy' presentations continue to be complicated at follow-up, but with
chronic course and continued impairment (8, 125; SY Kahana, EA Youngstrom, JR
Calabrese and RL Findling, unpublished data). These findings strongly suggest that mood
symptoms failing to meet strict DSM or ICD thresholds are not simply typical juvenile
behavior, or in most cases do they appear to spontaneously remit. At the same time, it
remains unclear whether the majority of youths so affected will develop more `classic'
bipolar presentations.
Neurobiology
When comparing pediatric BD versus healthy volunteers, findings include increased
ventricular size (126, 127), decreased thalamic size (128), decreased intracranial volume
(127), elevated glutamate / glutamine in both frontal lobes and basal ganglia (129), and
possible increases in anterior cingulated myo-inositol / creatine that decrease in response to
lithium therapy (130). However, none of these differences have demonstrated statistically
significant separations between BD versus schizophrenia (127, 128), raising questions about
whether these changes are indications of general pathology (131). This ambiguity heightens
the need for studies including an ADHD comparison group when investigating pediatric BD,
to identify when pathophysiology might be specific to pediatric BD.
Imaging studies have found decreased amygdalar volumes in youths with bipolar (132–137),
in contrast to the finding of enlarged amygdalar volumes in adults with BD (138, 139).
However, functional magnetic resonance imaging with emotion tasks in both age groups
have consistently demonstrated differences in activation in circuitry implicated in the
recognition and regulation of emotions (140), converging evidence from affective startle
probes, and other neuroscience methods (141–143). These preliminary findings implicate
emotion regulation systems in BD across the age ranges investigated (134, 144).
Special topics
Functional impairment and quality of life
Pediatric BD involves considerable functional impairment and reduces quality of life for
both the affected youths and their families (1). In terms of level of functioning, the average
Global Assessment of Functioning or Child Global Assessment Scale score for youths with
research diagnoses of bipolar I ranges between 43 and 50, and the average for youths with
other bipolar spectrum diagnoses ranges from 49 to 55 (8, 17, 44, 145, 146). These are well
below the accepted threshold of 60 that connotes clinical `caseness' (147).
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Pediatric BD is associated with aggressive behavior, attention problems, anxious and
depressed symptoms, delinquent behavior, social problems, withdrawal, and thought
problems (in descending order) (4, 148, 149). Youths with pediatric BD were showing mean
levels of these problems that exceeded the problems reported in 94% of age- and sex-
matched peers in a nationally representative standardization sample (150, 151). The level of
aggressive behavior reported across the pediatric BD samples (T = 77), exceeds the level of
behavior problems reported for 996 per 1,000 youths in the standardization samples. Self-
report and teacher-reported data on the same behavioral domains show lower levels of
impairment than indicated by parent-report (145, 148, 152, 153); however, youths with
pediatric BD still show statistically significant elevations on externalizing behavior
problems according to both youth and teacher report, and the level of impairment is
significantly higher than would be expected based on the typical level of agreement between
parents, youths, and teachers about functioning (45).
Direct interviews of the parent and youth about psychosocial functioning suggest that youths
with pediatric BD experience significantly less maternal–child warmth, more tension
between the child and the mother and father, and more impaired peer relationships than
youths with ADHD or no diagnosis (154). Even in a non-clinical epidemiologic sample,
pediatric BD was associated with high rates of treatment seeking (56%), social impairment
(67%), family impairment (56%), and school impairment (83%) based on the Kiddie
Schedule for Affective Disorders and Schizophrenia interviews with the adolescent (57).
More strikingly, youths with `subsyndromal' BD (defined as not meeting criteria for bipolar
I, bipolar II, or cyclothymia, yet who reported a period of elated / irritable mood associated
with at least one other DSM-III-R symptom of mania – called `core positive' bipolar NOS)
showed levels of impairment that were not statistically different than found with major
depressive disorder, with more than 50% of cases reporting impairment in at least one
setting, and 39% seeking treatment (57). Longitudinal follow-up indicates that through age
18 years, 44% of cases with bipolar diagnoses (excluding bipolar NOS) attempted suicide,
versus 22% of cases with major depressive disorder, 18% of `core-positive' bipolar NOS
cases, and only 1% of cases with no diagnosis (155). Bipolar disorder was associated with
the highest rates of suicidal ideation (72% of cases, versus 52% of major depressive
disorder, 41% of core positive bipolar NOS, and 6% of participants with no diagnosis), as
well as a younger age at first attempt (mean of 13.3 years), higher rates of multiple attempts
(88% of cases), and significantly greater medical lethality of attempts (155).
Personality / temperament
From Kraepelin forward, there has been recognition that there are temperamental qualities
associated with bipolar spectrum illness (48, 156). Investigations in youths at risk by dint of
having parents affected with BD tend to show higher levels of trait negative affect, lower
activity, and poorer sleep and rhythmicity (157). A comparison of temperament in youths
diagnosed with prepubertal or early adolescent bipolar disorder (PEA-BD) (requiring elated
mood and / or grandiosity) versus youths with ADHD and no comorbid mood, or normal
controls, found that PEA-BD was associated with higher novelty seeking, and the PEA-BD
group also differed from normal controls in terms of lower reward dependence, lower
persistence, less self-direction, and lower cooperativeness (158).
Clinical utility
There are several important ways in which the diagnosis of pediatric BD has demonstrated
clinical utility. One is its predictive value: pediatric BD has robust associations with
measures of symptomatology, impairment, and caregiver burden. The pediatric BD
diagnosis also shows prognostic value: youths with BD are at higher risk for suicidality,
substance use, and juvenile offending and incarceration (44, 155). Although many youths
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experience periods of improvement, rates of relapse / recurrence are high and episodes tend
to be long (8, 44), with youths typically spending most weeks of a given year experiencing
impaired mood (8). Thus, identifying that a youth meets criteria for BD communicates
important information about their long-term risk for critical outcomes.
The pediatric BD diagnosis is also accruing substantial prescriptive value. A correct
diagnosis of pediatric BD indicates a set of treatment strategies, including pharmacologic
mood stabilization using lithium, divalproex, or atypical antipsychotics (13, 159), as well as
psychosocial interventions concentrating on psychoeducation (160), family functioning (86),
or modified versions of cognitive behavioral therapy designed to address the distinct issues
involved in mania versus depression, as well as the triggers associated with mood
dysregulation (161–163). These treatment recommendations were initially extrapolated from
experience with treating adult BD, but increasingly they are being supported by clinical
trials with pediatric samples. The consistency of treatment response in youths versus adults
is circumstantial evidence suggestive of the validity of the diagnosis in youths (9).
The diagnosis of pediatric BD also has clinical utility by contraindicating treatments that are
ineffective at stabilizing moods. Undiagnosed pediatric BD will rarely be mistaken for
normal functioning, and instead will lead to well-intentioned treatments for other conditions.
Although available evidence strongly suggests that stimulant medication is well tolerated in
pediatric BD when mood stabilizers are already started, there is concern that the use of
stimulants or antidepressants without concomitant mood stabilization could provoke new
manic or mixed attacks (117, 164, 165). The evidence for pharmacotoxicity, or medications
inducing new manic episodes, is currently ambiguous (166), but clearly there is clinical
value in a diagnosis that focuses attention on efficacious interventions and proscribes
treatments that are at best ineffective and at worst harmful.
Dimensional versus categorical diagnosis and the boundary problem
It is uncertain whether pediatric BD represents a distinct category of illness, versus
involving the expression of extremes in mood and temperamental tendencies that are present
to varying degrees throughout the population. On one hand, diagnoses of pediatric BD and
its subtypes can be made reliably (22, 23). Pediatric BD diagnoses have also demonstrated
compelling evidence of clinical validity, as well as neuropsychological features and familial
aggregation with other mood disorders. On the other hand, the evidence could also be
interpreted as a continuum of impairment and symptom severity, with bipolar I being the
most extreme presentation along a continuum that includes bipolar II, cyclothymia, and
bipolar NOS or `core positive' cases (14), and perhaps shading into the `broad phenotype' of
severe mood dysregulation (60) as well as non-impairing variations in temperament. The
current diagnostic categories have not been proven to reflect true qualitative differences in
presentation or quantitative differences in course and outcome.
Another possibility is that there might be subtypes of illness that have not been accurately
demarcated yet. For example, the high rate of comorbidity with ADHD in cases of pediatric
BD is consistent with new data indicating that episodic problems with attention and energy
may be prodromes of BD (53). There are similar issues attached to the high rates of
comorbidity with conduct problems (167) and anxiety (8). Finally, there are data suggesting
that clinically meaningful distinctions should be made between a `Cade's Disease'
presentation involving good premorbid functioning, distinct mood episodes, reasonable
inter-episode functioning, and elated mood during at least some manic episodes (55), versus
a clinical picture that involves more frequent mood episodes with more mixed states, and
more gradual onset and offset or more chronic presentation (56, 168). However, none of
these boundaries have yet been formally tested using statistical models specifically designed
to evaluate the hypothesis that there are categories or subtypes versus a continuum of
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behavior (169). It is noteworthy that the available evidence is most consistent with a
polygenic model for BD. Apparent comorbidities could be due to some `bipolar' cases also
having genes implicated in other disorder phenotypes, and also in some `bipolar' genes
occurring in youths with other non-bipolar diagnoses.
Conclusion and recommendations
Considerable progress has been made in validating the diagnosis of BD in children and
adolescents. There exists a group of youths whose symptom presentation meets strict DSM-
IV criteria for bipolar spectrum diagnoses, and there is a broader spectrum of cases that
show symptoms of mania without meeting full criteria for a DSM diagnosis. Youths with
bipolar spectrum diagnoses show considerable impairment, a strong familial association
with mood disorder (and BD in particular), and morphological features and neuroaffective
functioning that are consistent with findings in adults with BD, all of which are suggestive
of continuity between the pediatric and adult diagnoses. The pattern of comorbid diagnoses
and associated clinical features is generally consistent across research groups investigating
pediatric samples, and appears broadly consistent between youth and adult findings insofar
as investigations have measured comparable diagnoses.
The main points that are often considered to be differences between pediatric versus adult
presentation, upon close examination, do not appear to offer substantial challenges to the
validity of the pediatric bipolar diagnosis. What has been characterized as `ultra-rapid' or
`ultradian' cycling in youths appears to be a clinical presentation that would be described as
a `mixed state' in adult psychiatry. This sort of mixed presentation is both common in adults
with BD, and it is associated with features making it plausible that it would be prevalent in
youths (170). Many other critiques of pediatric BD have concentrated on how the modal
presentation in youths differs from the `classic' bipolar presentation (32, 70, 171). However,
adult BD extends well beyond the boundaries of `Cade's Disease' to encompass a broad
spectrum of presentations, including predominantly rapid cycling and mixed states, or
manias dominated by irritable instead of euphoric mood (172, 173). Adult studies are also
beginning to document the existence of a `soft spectrum' of bipolar illness, marked by
shorter duration of mood states that appears highly prevalent and also associated with the
potential for clinical impairment (174). The growing expectation is that there will be
considerable developmental continuity between pediatric BD and adult presentations, where
affected youths will continue to show more mixed states, frequent relapse, poorer response
to lithium monotherapy, and the other features associated with non-classic presentation (54).
Schema for diagnosis
Clinicians and researchers should be open to the possibility of making a bipolar diagnosis in
youths and adolescents, in light of the mounting prevalence data suggesting that affected
cases are presenting to most types of clinical infrastructure. Cues that should trigger detailed
assessment include a family history of mood disorder - and especially of BD - episodes of
aggressive behavior (particularly in the context of other manic symptoms), early age of
onset for depression, mood disorder with psychotic features, recurrent depressive episodes
that are resistant to treatment (suggesting possible bipolar II), episodic presentation of
symptoms otherwise appearing similar to ADHD, and mood destabilization secondary to
trials of stimulant or antidepressant medications. It makes sense to screen for family history
of BD and to have a familiar adult complete a lifetime screener for manic symptomatology
in the youth prior to initiating pharmacologic treatment for depression or for complicated
presentations of attention problems or anxiety.
The DSM and ICD set of symptoms appear to also apply to BD in youths, with some
allowance made for developmental constraints on expression (175). However, `bizarre
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appearance' and `lack of insight' both show serious problems in terms of construct validity as
associated features of mania (37). Diagnosis should routinely involve a collateral informant
familiar with the child's behavior. Diagnostic interviews should also involve interview and
observation of the youth, even though the youth's capacity to complete a formal interview
might be limited. Direct interview of the youth offers opportunities to observe signs of
pervasive developmental disorder that could contribute to poor frustration tolerance and
symptoms that might be misattributed to mood disorder, as well as to ask youths about
aspects of mood and cognitive functioning not readily observed by others (176, 177).
Confidence in a bipolar diagnosis increases when there is evidence of changes in mood that
are associated with multiple other manic symptoms, particularly symptoms that are more
specific to BD (although it must be kept in mind that some legitimate bipolar cases will not
show these more specific symptoms). The manifestation of these symptoms in multiple
settings also increases confidence in the diagnosis and provides a clinical marker for more
severe impairment. However, given the low level of inter-rater agreement about youth
behavior in general, often one informant will be much more concerned about mood
symptoms than others. Family history and screening instruments will be helpful diagnostic
aids, but they will not be decisive by themselves and cannot substitute for a careful
diagnostic interview.
Diagnosticians need to attend to issues of comorbidity and symptom overlap. As outlined in
Table 1, many symptoms could easily be due to other disorders either instead of or
superimposed on top of a mood disorder. Some qualitative distinctions have been made
between the characteristic phenomenology of symptoms in the context of a mood episode
versus in the context of anxiety, ADHD, or conduct disorders (5, 171, 178, 179). One of the
recurring themes in differentiating mood symptoms from other disorders is that anxiety,
ADHD, and conduct disorder all tend to be associated with more chronic presentations of
the behaviors, whereas mood symptoms may have more of a tendency to fluctuate. The
DSM and ICD frameworks also require that the symptoms of anxiety, inattention, motor
activity, psychosis, or rule-breaking behavior be present during periods of euthymia to
warrant the addition of a separate `comorbid' diagnosis. Diagnosis can be aided by assessing
changes in mood and energy both retrospectively and prospectively over the course of
treatment, via techniques such as the life charting method, or clinical evaluation at
subsequent treatment visits.
The current DSM criteria for a manic episode, mixed state, hypomanic episode, and
depressive episode all appear reasonably validated for application to children and
adolescents, with the possible exception of duration criteria. When describing mood
presentation in children, it would be helpful to label unstable, oscillating shifts between
manic and depressed poles within the course of the same week (or same day) as a form of
`mixed episode,' rather than multiple `cycles' of episodes (42, 180). The validity of
hypomania in children is less clear, both because it is challenging to distinguish from
behavior `within normal limits' for age, and also because of the frequency of oscillating
mixed presentations. The four-day duration requirement for hypomania has not been
supported by data in adults (174), and four days is likely to be longer than the typical
duration of hypomania in youths as well. It would be useful to add `mixed hypomania' as a
mood state to capture episodes with hypomanic symptoms mingled with depressive
symptoms. Such a category would better convey that the presentation appears to be on the
bipolar spectrum than would labels such as `depression' or `agitated depression.'
Cyclothymia is rarely diagnosed either clinically (4) or in research (8, 17, 44), and much less
is known about the validity of it as a diagnostic label in youths. Many are `lumping' clinical
presentations that could fit criteria for cyclothymia into the bipolar NOS category. The long
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duration (at least 1 year with no more than 2 months free of symptoms) and the exclusion of
severe mood episodes (which would change the diagnosis if they reached sufficient acuity
for a depressed, manic, or mixed state) make it challenging to differentiate cyclothymia both
from temperament and also from common diagnoses with more chronic presentations. When
bipolar NOS is diagnosed, it would be helpful to indicate the subtype of NOS involved (see
Table 2), to help gain experience with the validity of the different types (60). Finally, one of
the most clinically valuable distinctions may be between those cases with distinct mood
episodes (especially with good premorbid or inter-episode functioning) versus those with
more chronic mood dysregulation and insidious onset. Although not yet reflected in formal
DSM or ICD guidelines, it is becoming evident that this distinction between `Cade's Disease'
or a `narrow phenotype' versus a more `broad phenotype' provides important information
about prognosis and treatment selection (56).
Principal areas of disagreement
There are several remaining areas of controversy, including the relative role of elated versus
irritable mood, the boundaries of the `broad phenotype' of pediatric BD, and the question of
whether DSM identifies the most clinically relevant categories or subtypes of BD. More
work needs to employ theoretically driven models of aggression. Aggression in the context
of a mood disorder may be more reactive and less proactive, more impulsive and less planful
or instrumental – in short, more likely to be `hot' rather than `cold' aggression (181).
Aggression might be linked to interpersonal status and social dominance in the family or
peer group, consistent with older emotion models of depression (182) and also with the high
rejection sensitivity often observed in BD (183).
How broad is the `broad phenotype'?
Clinical presentations that involve mood dysregulation range from single episodes of
depression or mania in otherwise well-functioning individuals, through rapid cycling
[operationally defined as four distinct mood episodes in the course of a year, regardless of
polarity (40, 47)], into more chronic presentations of rapidly fluctuating or oscillating
moods. In adults, chronic yet oscillating or labile mood disturbance is a frequent clinical
presentation that could be conceptualized variously as a long duration of a mixed episode,
rapid cycling BD, cyclothymia, or borderline personality disorder (54). There is relatively
little controversy about diagnosis of cases with distinct mood episodes and acute onset, even
in youths – the `Cade's Disease' presentation. However, this presentation appears to be rare
in childhood. The more chronic and oscillating presentation appears to be much more
prevalent. Different operational definitions of `broad phenotypes' or bipolar NOS have been
offered (60), all of which need rigorous testing with data collected in a methodologically
stringent fashion.
Priority areas for future work
Continued longitudinal studies of both `at risk' (53, 157, 184) as well as `already identified'
(8, 44, 185) samples are essential to understand developmental continuity between pediatric
`bipolar disorder' and adult BD. Studies where clinicians with experience in one age group
have the opportunity to evaluate patients in a different age group also deserve emphasis. The
balkanization of the field into `child,' `adult,' and `late life' specializations hampers
understanding of development and change.
Epidemiological studies that involve interviews with collateral informants, and that adapt
probes and anchors to assess for mania in pediatric contexts, also should be a priority, along
with re-analyses and add-on studies in samples ascertained for related disorders or
behaviors. For example, longitudinal studies of ADHD should include a subset of youths
likely to develop BD if prior estimates of comorbidity are accurate (186, 187). Investigations
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in samples ascertained for antisocial behavior and work in forensic settings will also be vital
to clarify the boundaries between mania and other disorders affecting impulse control.
The most obvious, and from the consumer's perspective, the most important area for
continued research is the arena of treatment. Until there are well-tolerated interventions that
can produce remission and promote positive functioning in the majority of cases, or until
there is effective and safe prophylaxis available, then the treatment of pediatric BD deserves
to be one of the highest priorities in the mental health research agenda.
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Hyperacuisis - experiencing sensations as being
unusually vivid or intense
Unknown Unknown Needs investigation






















BD = bipolar disorder; CD/APD = Conduct disorder/Antisocial Personality Disorder; ADHD = attention-deficit hyperactivity disorder; PTSD =
post-traumatic stress disorder; ICD-10 = International Classification of Diseases, 10th edition; CBCL = Child Behavior Checklist; PGBI = Parent
General Behavior Inventory; WASH-U-KSADS = Washington University Kiddie Schedule for Affective Disorders and Schizophrenia.
a
The 'Features Suggestive of Other Diagnoses' are not exhaustive, but provide clinical examples often encountered.
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Table 2
Different definitions of bipolar disorder not otherwise specified and the 'broad phenotype' of pediatric bipolar
disorder
Definition (source) Comment
Cyclothymia (DSM-IV-TR) Technically not considered a type of 'bipolar NOS' in DSM
Rarely diagnosed in children or adolescents in research or
clinical settings (4)
Many research groups lump cyclothymia together with bipolar
NOS (8)
Difficult to disentangle from normal development,
temperament, and comorbid conditions due to the requirement
that patient not meet criteria for full manic, mixed, or major
depressive episode during initial year of illness
Still possible to diagnose reliably, and associated with a
significant amount of impairment (59)
Repeated hypomanias in the absence of lifetime mania or depression (DSM-
IV-TR)
Unlikely to be impairing enough to lead to treatment seeking;
thus not observed clinically
Challenging to differentiate from behavior within
developmental normal limits
Insufficient duration of mood episodes (DSM-IV-TR) Leibenluft et al. (60)
further distinguish between cases with elated mood and/or grandiosity versus
those with only irritability as mood disturbance; following Geller and Luby
(5)
This appears to be a common presentation (59)
It is associated with a high degree of impairment (14, 59)
This definition may include cases with mood severity that
would otherwise warrant a diagnosis of manic, mixed, or
depressive state
Also may include cases with mixed states that involve polarity
shifts if the diagnostician expects a week's worth of duration
for either polarity
Important to note that adult data are calling durations into
question (174)
Insufficient number of manic symptoms Leibenluft et al. (60) include
'Irritable hypomania' and 'irritable mania' as another 'intermediate' phenotype,
even if accompanied by four or more other manic symptoms
This also appears to be more prevalent than cases meeting
strict DSM criteria for bipolar I or II, both in adolescent data
(190) and in re-analyses of adult epidemiologic data (191)
Captures a much more heterogeneous group, and it is possible
to meet criteria for this category relying entirely on non-
specific symptoms (e.g., irritable mood plus distractibility,
high motor activity, and rapid speech)
Research designs typically have not documented episodicity of
symptoms (190, 191)
In spite of these caveats, this definition of NOS is still
associated with high rates of impairment and service utilization
(190, 191)
Severe mood dysregulation (previously referred to as a 'broad phenotype')
[Leibenluft et al., definition (60)]
Recommended criteria: abnormal mood (anger or sadness)
present at least half the day most days; accompanied by
'hyperarousal' (insomnia
a
, agitation, distractibility, racing
thoughts/flight of ideas; pressured speech, or social
intrusiveness
a
); also shows increased reactivity to negative
emotional stimuli compared to peers
a
; onset before age 12;
duration at least 12 months with no more than 2 months
symptom free; symptoms severe in at least one setting
Rule outs: elated mood, grandiosity, or episodically decreased
need for sleep; distinct episodes of 4+ days duration; meeting
criteria for schizophreniform, schizophrenia, pervasive
developmental disorder, or post-traumatic stress disorder; or
meeting criteria for a substance use disorder in the past 3
months; or IQ < 80; or symptoms are attributable to a
medication or general medical condition
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Definition (source) Comment
Comments: not yet tested against data. The exclusion of
episodicity and of several symptoms more specific to bipolar
disorder both are likely to select against bipolar spectrum
cases. The inclusion of chronic presentations and sensitive but
non-specific symptoms are likely to include many cases with
presentations that are not on the bipolar spectrum. This
category appears likely to include a blend of different
etiologies and mechanisms as a result
Bipolar NOS - research criteria from 'Course and Outcomes of Bipolar
Youth' Study (NIMH R01 MH059929; 8, 14)
Requires 'core positive' - presence of distinct period of
abnormally elevated, expansive, or irritable mood
Minimum of two other 'B Criteria' symptoms if mood is mostly
elated; at least three 'B Criteria' if irritable
Requires clear change from individual's typical functioning
(consistent with DSM-IV and ICD guidelines for hypomania)
Requires 4+ h of mood within a 24-h period to be counted as
an index 'day' of disturbance
Requires 4+ days at a minimum over the course of a lifetime to
diagnose bipolar NOS; non-consecutive days are acceptable
Beginning to garner empirical support (8, 14)
Needs replication in other samples/research groups
Child Behavior Checklist proxy diagnosis [after Mick et al. (149), used in
subsequent re-analyses (186, 187)]. Often operationally defined as parent-
reported T-scores of 70+ on Aggressive Behavior, Attention Problems, and
Anxious/Depressed scales
Convenient to use for large sample studies
Avoid problems of rater training and anchoring effects
Prone to factors that might bias parent report
Does not capture diagnostically specific symptoms; instead
concentrates on sensitive symptoms that might also have high
false-positive rate
Focuses on symptoms that are likely to be 'shared' with other
disorders at a genetic level
Concerns that agreement with clinical or research-
interviewderived (KSADS) diagnoses of bipolar spectrum
might be modest
NOS = not otherwise specified; KSADS = Kiddie Schedule for Affective Disorders and Schizophrenia.
a
Symptom is not part of current DSM-IV nosology for mania.
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